Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
M Kimachi, TA Furukawa, K Kimachi… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic kidney disease (CKD) is an independent risk factor for atrial fibrillation
(AF), which is more prevalent among CKD patients than the general population. AF causes …
(AF), which is more prevalent among CKD patients than the general population. AF causes …
[HTML][HTML] Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations
Cerebral microbleeds (microbleeds) are small, punctuate hypointense lesions seen in T2*
Gradient-Recall Echo (GRE) and Susceptibility-Weighted (SWI) Magnetic Resonance …
Gradient-Recall Echo (GRE) and Susceptibility-Weighted (SWI) Magnetic Resonance …
Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman… - The Lancet, 2014 - thelancet.com
Background Four new oral anticoagulants compare favourably with warfarin for stroke
prevention in patients with atrial fibrillation; however, the balance between efficacy and …
prevention in patients with atrial fibrillation; however, the balance between efficacy and …
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
S Halvorsen, D Atar, H Yang… - European heart …, 2014 - academic.oup.com
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL …
LPT Joosten, S van Doorn, PM van de Ven… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: There is ambiguity whether frail patients with atrial fibrillation managed with
vitamin K antagonists (VKAs) should be switched to a non–vitamin K oral anticoagulant …
vitamin K antagonists (VKAs) should be switched to a non–vitamin K oral anticoagulant …
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
M Aronsson, E Svennberg, M Rosenqvist… - Ep …, 2015 - academic.oup.com
Aims The aim of this study was to estimate the cost-effectiveness of 2 weeks of intermittent
screening for asymptomatic atrial fibrillation (AF) in 75/76-year-old individuals. Methods and …
screening for asymptomatic atrial fibrillation (AF) in 75/76-year-old individuals. Methods and …
[HTML][HTML] The Significance of drug—Drug and drug—Food interactions of oral anticoagulation
P Vranckx, M Valgimigli… - … & electrophysiology review, 2018 - ncbi.nlm.nih.gov
Vitamin K antagonists (VKAs) such as warfarin are the most commonly prescribed oral
anticoagulants worldwide. However, factors affecting the pharmacokinetics of VKAs, such as …
anticoagulants worldwide. However, factors affecting the pharmacokinetics of VKAs, such as …
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …
C Held, EM Hylek, JH Alexander, M Hanna… - European heart …, 2015 - academic.oup.com
Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of …
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of …
Safety and efficacy of well managed warfarin
V Sjögren, B Grzymala-Lubanski… - Thrombosis and …, 2015 - thieme-connect.com
The safety and efficacy of warfarin in a large, unselected cohort of warfarin-treated patients
with high quality of care is comparable to that reported for non-vitamin K antagonists …
with high quality of care is comparable to that reported for non-vitamin K antagonists …